|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Integrated preclinical and clinical development of S- trans, trans -farnesylthiosalicylic acid (FTS, Salirasib) in pancreatic cancer显示文摘 | Daniel Laheru Preeti Shah N. V. Rajeshkumar Florencia McAllister Gretchen Taylor Howard Goldsweig Dung T. Le Ross Donehower Antonio Jimeno Sheila Linden Ming Zhao Dongweon Song Michelle A. Rudek Manuel Hidalgo | 2012 | Investigational New Drugs2012，，6： | 2 |
| 2 | Cell:癌基因“遗传平衡”或会影响患者对癌症疗法的反应显示文摘进行癌症疗法的选择越来越需要确定肿瘤细胞中是否含有一些特殊突变的癌基因会驱动癌细胞异常生长。并且确定是否癌细胞会对特殊药物耐受或敏感.近日来自加州大学旧金山分校的研究人员就通过研究发现。以常见的癌基因KRAs突变为例。患者对疗法的反应往往会随着肿瘤的不断进化而发生改变。相关研究刊登于国际杂志Cell上。 | Michael R. Burgess Eugene Hwang Rana Mroue Craig M. Bielski Anica M. Wandler Benjamin J. Huang Ari J. Firestone Amy Young Jennifer A. Lacap Lisa Crocker Saurabh Asthana Elizabeth M. Davis Jin Xu Keiko Akagi Michelle M. Le Beau Qing Li Benjamin Haley David Stokoe Deepak Sampath Barry S. Taylor Marie Evangelista Kevin Shannon | 2017 | 现代生物医学进展2017，17，18： | 2 |
| 3 | 白内障的发展及其相关危险因素视力损害调查项目显示文摘目的:评估澳大利亚居民白内障的发展及其相关危险因素。
方法:对在维多利亚9个随机抽取的城区共3721个参加者做调查,进行全面的标准化的访谈和眼科检查作基线纪录及5年随访。根据Wilmer白内障分级系统对晶体混浊进行临床分级并照相。皮质性、核性、后囊下性白内障分别观察其发展和其相关危险因素。白内障发展的危险因素包括不同的社会人口统计,饮食。遗传性,医药干预和眼部特征。危险因素分析用单一和多元logistic回归法。 | Bickol N. Mukesh Anhchuong Le Peter N. Dimitrov Shazia Ahmed Hugh R. Taylor Catherine A. McCarty 刘亮(译) | 2006 | 美国医学会眼科杂志(中文版)2006，18，4： | 2 |
| 4 | Arterial biology for theinvestigation of the treatment effects of reducing cholesterol(ARBI-TER)2:a double-blind,placebo-controlled study of extended-re-lease niacin on atherosclerosis progression in secondary preventionpatients treated with statins显示文摘 | Taylor AJ Sullenberger LE Lee HJ | 2004 | Circulation2004，110，23： | 1 |
| 5 | The effect of 24 months ofcombination statin and extended-release niacin on carotid intima-media thickness:ARBITER 3显示文摘 | Taylor AJ Lee HJ Sullenberger LE | 2006 | Curr Med Res Opin2006，22，11： | 1 |
| 6 | New evidence from a calcite- dolomite carbonate dyke for the magmatic origin of the massive Bayan Obo ore-beating dolomite marble, Inner Mongolia, China显示文摘 | Le Bas M J Yang X M Taylor R N | 2007 | Mineralogy and Petrology2007，91，34： | 1 |
| 7 | Memory-like CD8+ and CD4+ T cells cooperate to break peripheral tolerance under lymphopenic conditions 显示文摘 | Le SC Mennechet S Taylor N | 2008 | Proc Natl Acad Sci U S A2008，105，19： | 1 |
| 8 | Interpersonal processes in social phobia 显示文摘 | Alden LE Taylor CT | 2004 | Clin Psychol Rev2004，24，7： | 1 |
| 9 | Simulation analysis of the consequences of shifting the balance of health care : a system dynamics approach 显示文摘 | Taylor K Dangerfield B Le Grand J | 2005 | J Health Serv Res Policy2005，10，4： | 1 |
| 10 | Progression of calcified coronary atherosclerosis: relationship to coronary risk factors and carotid intima-media thickness显示文摘 | Taylor AJ Bindeman J Le TP | 2008 | Atherosclerosis2008，197，： | 1 |
| 11 | Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic Adenocarcinomas显示文摘 | Robb E. Wilentz Gloria H. Su Jia Le Dai Andrew B. Sparks Pedram Argani Taylor A. Sohn Charles J. Yeo Scott E. Kern Ralph H. Hruban | 2000 | The American Journal of Pathology2000，，1： | 1 |
| 12 | To see ourselves as others see us: an experi- mental integration of the intra and interpersonal consequences of self-protection in social anxiety disorder 显示文摘 | Taylor CT Alden LE | 2011 | J Abnorm Psychol2011，120，1： | 1 |
| 13 | Progression of calcified coronary atherosclerosis:relationship to coronary risk factors and carotid intima-media thickness显示文摘 | Taylor AJ Bindeman J Le TP | 2008 | Atherosclerosis2008，197，1： | 1 |
| 14 | Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2:a double-blind,placebo-controlled study of extendedrelease niacin on atherosclerosisprogression in secondary prevention patients treated with statins显示文摘 | Taylor AJ Sullenberger LE Lee HJ | | 0，，23： | 1 |
| 15 | Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins显示文摘 | TAYLOR A J SULLENBERGER LE LEE H J | 2004 | Circulation2004，110，23： | 1 |
| 16 | Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo controlled study of ex- tended-release niacin on atheroselerosis progression in secondary prevention patients treated with statins 显示文摘 | Taylor AJ Sullenberger LE Lee H J | 2004 | Circulation2004，110，23： | 1 |
| 17 | Development of cataract and associated risk factors:the visual impairment project 显示文摘 | Mukesh BN Le A Dimitrov PN Ahmed S Taylor HR McCarty CA | 2006 | Arch Ophthalmol2006，124，1： | 1 |
| 18 | Progression of calcified coronary atherosclerosis: relationship to coronary risk factors and carotid in- tima-media thickness 显示文摘 | Taylor AJ Bindeman J Le TP | 2008 | Atherosclerosis2008，197，： | 1 |
| 19 | Arerial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 显示文摘 | Taylor AJ Sullenberger LE Lee HJ | 2004 | Circulation2004，110，9： | 1 |
| 20 | Pesticides and Parkinson’s disease显示文摘 | McLean AJ Taylor MC | 1999 | Biomed Pharmacother1999，53，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员